Epigral Ltd. (EPIGRAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has a cash flow conversion efficiency ratio of 0.056x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs630.15 Million ≈ $6.81 Million USD) by net assets (Rs11.28 Billion ≈ $122.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Epigral Ltd. - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Epigral Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Epigral Ltd. balance sheet liabilities for a breakdown of total debt and financial obligations.
Epigral Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Epigral Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Qinghai Huzhu Barley Wine Co Ltd
SHE:002646
|
0.000x |
|
AMERISAFE Inc
NASDAQ:AMSF
|
0.009x |
|
Qingdao Liqun Department Store Group Co Ltd
SHG:601366
|
0.155x |
|
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439
|
0.017x |
|
Indointernet Tbk PT
JK:EDGE
|
0.095x |
|
MERSEN UNSP.ADR 1/5 EO 2
F:CBE0
|
N/A |
|
COGNYTE SOFTWARE LTD
F:81M
|
0.087x |
|
Peoples Fin
NASDAQ:PFIS
|
0.029x |
Annual Cash Flow Conversion Efficiency for Epigral Ltd. (2015–2025)
The table below shows the annual cash flow conversion efficiency of Epigral Ltd. from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Epigral Ltd..
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs19.05 Billion ≈ $205.97 Million |
Rs4.41 Billion ≈ $47.64 Million |
0.231x | -27.04% |
| 2024-03-31 | Rs12.54 Billion ≈ $135.63 Million |
Rs3.98 Billion ≈ $43.00 Million |
0.317x | -45.86% |
| 2023-03-31 | Rs10.69 Billion ≈ $115.62 Million |
Rs6.26 Billion ≈ $67.72 Million |
0.586x | +49.81% |
| 2022-03-31 | Rs7.26 Billion ≈ $78.51 Million |
Rs2.84 Billion ≈ $30.69 Million |
0.391x | +16.69% |
| 2021-03-31 | Rs6.84 Billion ≈ $73.99 Million |
Rs2.29 Billion ≈ $24.79 Million |
0.335x | +18.71% |
| 2020-03-31 | Rs5.83 Billion ≈ $63.10 Million |
Rs1.65 Billion ≈ $17.81 Million |
0.282x | -46.78% |
| 2019-03-31 | Rs4.93 Billion ≈ $53.29 Million |
Rs2.61 Billion ≈ $28.26 Million |
0.530x | +22.00% |
| 2018-03-31 | Rs5.17 Billion ≈ $55.95 Million |
Rs2.25 Billion ≈ $24.32 Million |
0.435x | +13.58% |
| 2017-03-31 | Rs3.62 Billion ≈ $39.12 Million |
Rs1.38 Billion ≈ $14.97 Million |
0.383x | -8.46% |
| 2016-03-31 | Rs2.95 Billion ≈ $31.92 Million |
Rs1.23 Billion ≈ $13.35 Million |
0.418x | -17.91% |
| 2015-03-31 | Rs2.20 Billion ≈ $23.82 Million |
Rs1.12 Billion ≈ $12.13 Million |
0.509x | -- |
About Epigral Ltd.
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar … Read more